It’s what drives you and us in the search for better treatment options for estrogen receptor (ER)–positive, human epidermal growth factor receptor 2 (HER2)–negative, locally advanced (recurrent or progressed) or metastatic breast cancer.

It’s what drives you and us in the search for better treatment options for estrogen receptor (ER)–positive, human epidermal growth factor receptor 2 (HER2)–negative, locally advanced (recurrent or progressed) or metastatic breast cancer.

PersevERA is a phase 3 clinical study evaluating a next-generation investigational treatment.

Discuss with your doctor if the persevERA study is right for you.

Am I Eligible?